Xcout Intel
ADNTRO
ADNTRO is a genetics company offering at-home DNA tests that provide over 300 reports across seven categories, including ancestry, nutrition, fitness, and longevity. The company is headquartered in Artà, Spain.
Subscribe to see ADNTRO’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ADNTRO at a glance
ADNTRO is a healthtech company headquartered in Spain. Its most recent funding round, Seed, closed in October 2024. Xcout tracks 9 named people at ADNTRO, including Guillermo Monzón (Fundador y CEO).
ADNTRO leadership
- Guillermo MonzónFundador y CEO
- Jorge Blom-DahlCofundador y CTO
- Alberto GarcíaDesarrollo full stack
- Dr. Jair Tenorio-CastañoGenetista
- Dra. Marta Alonso-BernáldezNutrigenética
- Estefanía MontesDiseño de producto y frontend
3 more named people on record for ADNTRO, with roles, board committees and tenure — see the full roster →
ADNTRO funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | Undisclosed | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
ADNTRO competitors
A few of ADNTRO's closest competitors — see the full list of competitors and alternatives →
24Genetics is a Spain-based genetic testing company that analyzes DNA samples, typically collected with a saliva kit, to provide reports on areas such as ancestry, health predispositions, nutrition, pharmacogenetics, skin, and sports genetics. It serves individual consumers as well as organizations and healthcare-related professionals seeking personal genetic information and testing services.
BIOMES is a German deep-biotech brand headquartered in Wildau, Germany. The company specializes in analyzing the intestinal microbiome to provide personalized health and wellness recommendations.
Rightangled is a UK healthtech company that provides genetic and pharmacogenomic testing to help identify how individuals may respond to medicines. It serves patients and healthcare professionals seeking more personalized treatment and medication decisions.
DayTwo is an Israeli digital-health company that provides personalized nutrition recommendations using gut-microbiome analysis, blood-glucose data, and machine-learning models. Its programs are aimed at improving metabolic health, including for people with diabetes or prediabetes, and are delivered through healthcare and employer channels.
Get ADNTRO's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ADNTRO in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access